These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17710152)

  • 1. Long-term protection against HBV chronic carriage of Gambian adolescents vaccinated in infancy and immune response in HBV booster trial in adolescence.
    van der Sande MA; Waight PA; Mendy M; Zaman S; Kaye S; Sam O; Kahn A; Jeffries D; Akum AA; Hall AJ; Bah E; McConkey SJ; Hainaut P; Whittle HC
    PLoS One; 2007 Aug; 2(8):e753. PubMed ID: 17710152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986-90) and in the nationwide immunisation program.
    Peto TJ; Mendy ME; Lowe Y; Webb EL; Whittle HC; Hall AJ
    BMC Infect Dis; 2014 Jan; 14():7. PubMed ID: 24397793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study.
    Chang YC; Wang JH; Chen YS; Lin JS; Cheng CF; Chu CH
    BMC Public Health; 2014 Sep; 14():991. PubMed ID: 25248369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages.
    Whittle HC; Maine N; Pilkington J; Mendy M; Fortuin M; Bunn J; Allison L; Howard C; Hall A
    Lancet; 1995 Apr; 345(8957):1089-92. PubMed ID: 7715343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan.
    Su FH; Bai CH; Chu FY; Lin YS; Su CT; Yeh CC
    Vaccine; 2012 Jun; 30(27):4034-9. PubMed ID: 22531558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China.
    Wang ZZ; Gao YH; Lu W; Jin CD; Zeng Y; Yan L; Ding F; Li T; Liu XE; Zhuang H
    Hum Vaccin Immunother; 2017 Apr; 13(4):909-915. PubMed ID: 27874311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination.
    Zhu CL; Liu P; Chen T; Ni Z; Lu LL; Huang F; Lu J; Sun Z; Qu C
    Vaccine; 2011 Oct; 29(44):7835-41. PubMed ID: 21816197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term protection against carriage of hepatitis B virus after infant vaccination.
    van der Sande MA; Waight P; Mendy M; Rayco-Solon P; Hutt P; Fulford T; Doherty C; McConkey SJ; Jeffries D; Hall AJ; Whittle HC
    J Infect Dis; 2006 Jun; 193(11):1528-35. PubMed ID: 16652281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of compulsory and booster doses of hepatitis B vaccine among children in Cairo, Egypt.
    Salama I; Sami S; Saleh R; Mohsen A; Elserougy S; Emam H; Said Z
    J Egypt Public Health Assoc; 2017 Jun; 92(2):77-85. PubMed ID: 30184404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early and long term anamnestic response to HBV booster dose among fully vaccinated Egyptian children during infancy.
    Salama II; Sami SM; Said ZN; Salama SI; Rabah TM; Abdel-Latif GA; Elmosalami DM; Saleh RM; Abdel Mohsin AM; Metwally AM; Hassanin AI; Emam HM; Hemida SA; Elserougy SM; Shaaban FA; Fouad WA; Mohsen A; El-Sayed MH
    Vaccine; 2018 Apr; 36(15):2005-2011. PubMed ID: 29530634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Are teenagers immunized in infancy still protected against hepatitis B?].
    Pokorska-Lis M; Marczyńska M
    Przegl Lek; 2010; 67(1):13-7. PubMed ID: 20509565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.
    Zanetti AR; Mariano A; Romanò L; D'Amelio R; Chironna M; Coppola RC; Cuccia M; Mangione R; Marrone F; Negrone FS; Parlato A; Zamparo E; Zotti C; Stroffolini T; Mele A;
    Lancet; 2005 Oct 15-21; 366(9494):1379-84. PubMed ID: 16226616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab.
    Moses J; Alkhouri N; Shannon A; Raig K; Lopez R; Danziger-Isakov L; Feldstein AE; Zein NN; Wyllie R; Carter-Kent C
    Am J Gastroenterol; 2012 Jan; 107(1):133-8. PubMed ID: 21876562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
    Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
    Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further observations on the immune response to recombinant hepatitis B vaccine after administration to aboriginal and Torres Strait Island children.
    Hanna JN; Faoagali JL; Buda PJ; Sheridan JW
    J Paediatr Child Health; 1997 Feb; 33(1):67-70. PubMed ID: 9069048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of immunity 18-19 years after vaccination against hepatitis B in 2 cohorts of vaccinees primed as infants or as adolescents in Italy.
    Romanò L; Galli C; Tagliacarne C; Tosti ME; Velati C; Fomiatti L; Chironna M; Coppola RC; Cuccia M; Mangione R; Marrone F; Negrone FS; Parlato A; Zotti CM; Mele A; Zanetti AR;
    Hum Vaccin Immunother; 2017 May; 13(5):981-985. PubMed ID: 28272974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B immune status in adolescents vaccinated during infancy: A retrospective cohort study from a pediatric practice in Germany.
    Anderson CL; Remschmidt C; Drobnitzky FP; Falkenhorst G; Zimmermann R; Wichmann O; Harder T
    Hum Vaccin Immunother; 2016 Mar; 12(3):779-84. PubMed ID: 26633195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination.
    Zhao YL; Han BH; Zhang XJ; Pan LL; Zhou HS; Gao Z; Hao ZY; Wu ZW; Ma TL; Wang F; Li Q; Bi SL; Ma JC
    BMC Infect Dis; 2019 May; 19(1):482. PubMed ID: 31146699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term protection against hepatitis B after newborn vaccination: 20-year follow-up.
    Roznovsky L; Orsagova I; Kloudova A; Tvrdik J; Kabieszova L; Lochman I; Mrazek J; Hozakova L; Zjevikova A; Pliskova L
    Infection; 2010 Oct; 38(5):395-400. PubMed ID: 20589522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observational study of vaccine efficacy 24 years after the start of hepatitis B vaccination in two Gambian villages: no need for a booster dose.
    Mendy M; Peterson I; Hossin S; Peto T; Jobarteh ML; Jeng-Barry A; Sidibeh M; Jatta A; Moore SE; Hall AJ; Whittle H
    PLoS One; 2013; 8(3):e58029. PubMed ID: 23533578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.